Borderline Resectable Pancreatic Adenocarcinoma (DBCOND0120269)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05688215	Zimberelimab and Quemliclustat in Combination with Chemotherapy for the Treatment of Patients with Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma	Calcium Fluorouracil Irinotecan Leucovorin Levoleucovorin Oxaliplatin Quemliclustat Zimberelimab	treatment	1 / 2	recruiting
NCT04669197	Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer	Cisplatin Gemcitabine Hydroxychloroquine Paclitaxel	treatment	2	active_not_recruiting
NCT05546411	A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer	Calcium Camptothecin Fluorouracil Irinotecan Leucovorin Nisevokitug Oxaliplatin	treatment	2	terminated
NCT04106856	Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)	Losartan	treatment	1	recruiting
NCT05825066	Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma	Gemcitabine Paclitaxel	treatment	2	recruiting
NCT04481204	New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study	Albumin human Chloride ion Cisplatin Fluorouracil Gemcitabine Irinotecan Leucovorin Oxaliplatin Paclitaxel Platinum	treatment	2	active_not_recruiting
NCT05083247	Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma	Gemcitabine Paclitaxel	treatment	2	recruiting
NCT02446093	Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma	Aglatimagene besadenovec	treatment	2	active_not_recruiting
NCT04484909	NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer	No drug interventions	treatment	1	active_not_recruiting
NCT03970252	Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer	Calcium Camptothecin Fluorouracil Irinotecan Leucovorin Levoleucovorin Nivolumab Oxaliplatin	treatment	0	completed
NCT04915417	Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma	No drug interventions	treatment	Not Available	unknown_status
NCT02394535	Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer	Albumin human Capecitabine Paclitaxel	treatment	1	completed
NCT04940286	Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer	Albumin human Durvalumab Gemcitabine Oleclumab Paclitaxel	treatment	2	recruiting
NCT05356039	Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer	No drug interventions	Not Available	Not Available	recruiting
NCT04423731	Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer	Fluorouracil Gemcitabine Leucovorin Paclitaxel	Not Available	Not Available	active_not_recruiting